ore severe stage of the disease (9, 170), indicating an impairment of polyfunctional T cells.
Li et al. (187) demonstrated that patients infected with SARS-CoV-1 had elevated levels of polyfunctional CD4+ T cells, especially those in a severe condition but who progressed to clinical improvement. In contrast, critically